People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling 'Magical' or dangerous? Health Canada warns against unauthorized peptides